[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Hereditary Angioedema Drug Market Report 2017

October 2017 | 100 pages | ID: UABD7213289PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Hereditary Angioedema Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Hereditary Angioedema Drug in these regions, from 2012 to 2022 (forecast).
United States Hereditary Angioedema Drug market competition by top manufacturers/players, with Hereditary Angioedema Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pharming Group NV
  • Shire plc
  • CSL Limited
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Product
    • C1 Esterase Inhibitor
    • Kallikrein Inhibitor
    • Selective Bradykinin B2 Receptor Antagonist
  • By Route of Administration
    • Oral
    • Intravenous
    • Subcutaneous Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hereditary Angioedema Drug for each application, including
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Hereditary Angioedema Drug Market Report 2017

1 HEREDITARY ANGIOEDEMA DRUG OVERVIEW

1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug by Product Category
  1.2.1 United States Hereditary Angioedema Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hereditary Angioedema Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 C1 Esterase Inhibitor
  1.2.4 Kallikrein Inhibitor
  1.2.5 Selective Bradykinin B2 Receptor Antagonist
1.3 United States Hereditary Angioedema Drug Market by Application/End Users
  1.3.1 United States Hereditary Angioedema Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 United States Hereditary Angioedema Drug Market by Region
  1.4.1 United States Hereditary Angioedema Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.5 New England Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.6 The South Hereditary Angioedema Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Hereditary Angioedema Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hereditary Angioedema Drug (2012-2022)
  1.5.1 United States Hereditary Angioedema Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Hereditary Angioedema Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hereditary Angioedema Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hereditary Angioedema Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hereditary Angioedema Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Hereditary Angioedema Drug Market Competitive Situation and Trends
  2.4.1 United States Hereditary Angioedema Drug Market Concentration Rate
  2.4.2 United States Hereditary Angioedema Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hereditary Angioedema Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEREDITARY ANGIOEDEMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hereditary Angioedema Drug Sales and Market Share by Region (2012-2017)
3.2 United States Hereditary Angioedema Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Hereditary Angioedema Drug Price by Region (2012-2017)

4 UNITED STATES HEREDITARY ANGIOEDEMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hereditary Angioedema Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hereditary Angioedema Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Hereditary Angioedema Drug Price by Type (2012-2017)
4.4 United States Hereditary Angioedema Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEREDITARY ANGIOEDEMA DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hereditary Angioedema Drug Sales and Market Share by Application (2012-2017)
5.2 United States Hereditary Angioedema Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEREDITARY ANGIOEDEMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pharming Group NV
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Shire plc
  6.2.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Shire plc Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Limited
  6.3.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 iBio Inc.
  6.4.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 iBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BioCryst Pharmaceuticals, Inc.
  6.5.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ionis Pharmaceuticals, Inc.
  6.6.2 Hereditary Angioedema Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 HEREDITARY ANGIOEDEMA DRUG MANUFACTURING COST ANALYSIS

7.1 Hereditary Angioedema Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hereditary Angioedema Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hereditary Angioedema Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEREDITARY ANGIOEDEMA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hereditary Angioedema Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hereditary Angioedema Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Hereditary Angioedema Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Hereditary Angioedema Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Hereditary Angioedema Drug
Figure United States Hereditary Angioedema Drug Market Size (MT) by Type (2012-2022)
Figure United States Hereditary Angioedema Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure United States Hereditary Angioedema Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Hereditary Angioedema Drug by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Hereditary Angioedema Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hereditary Angioedema Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hereditary Angioedema Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Hereditary Angioedema Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Hereditary Angioedema Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure 2017 United States Hereditary Angioedema Drug Sales Share by Players/Suppliers
Figure United States Hereditary Angioedema Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hereditary Angioedema Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hereditary Angioedema Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hereditary Angioedema Drug Revenue Share by Players/Suppliers
Figure 2017 United States Hereditary Angioedema Drug Revenue Share by Players/Suppliers
Table United States Market Hereditary Angioedema Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Hereditary Angioedema Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Hereditary Angioedema Drug Market Share of Top 3 Players/Suppliers
Figure United States Hereditary Angioedema Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hereditary Angioedema Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hereditary Angioedema Drug Product Category
Table United States Hereditary Angioedema Drug Sales (MT) by Region (2012-2017)
Table United States Hereditary Angioedema Drug Sales Share by Region (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Share by Region (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Market Share by Region in 2016
Table United States Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hereditary Angioedema Drug Revenue Share by Region (2012-2017)
Figure United States Hereditary Angioedema Drug Revenue Market Share by Region (2012-2017)
Figure United States Hereditary Angioedema Drug Revenue Market Share by Region in 2016
Table United States Hereditary Angioedema Drug Price (USD/Kg) by Region (2012-2017)
Table United States Hereditary Angioedema Drug Sales (MT) by Type (2012-2017)
Table United States Hereditary Angioedema Drug Sales Share by Type (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Share by Type (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Market Share by Type in 2016
Table United States Hereditary Angioedema Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hereditary Angioedema Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Type (2012-2017)
Figure Revenue Market Share of Hereditary Angioedema Drug by Type in 2016
Table United States Hereditary Angioedema Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Growth Rate by Type (2012-2017)
Table United States Hereditary Angioedema Drug Sales (MT) by Application (2012-2017)
Table United States Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Market Share by Application (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Market Share by Application in 2016
Table United States Hereditary Angioedema Drug Sales Growth Rate by Application (2012-2017)
Figure United States Hereditary Angioedema Drug Sales Growth Rate by Application (2012-2017)
Table Pharming Group NV Basic Information List
Table Pharming Group NV Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table Shire plc Basic Information List
Table Shire plc Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure Shire plc Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure CSL Limited Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table iBio Inc. Basic Information List
Table iBio Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure iBio Inc. Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table BioCryst Pharmaceuticals, Inc. Basic Information List
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information List
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Growth Rate (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Market Share in United States (2012-2017)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Drug
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Hereditary Angioedema Drug Industrial Chain Analysis
Table Raw Materials Sources of Hereditary Angioedema Drug Major Players/Suppliers in 2016
Table Major Buyers of Hereditary Angioedema Drug
Table Distributors/Traders List
Figure United States Hereditary Angioedema Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Hereditary Angioedema Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hereditary Angioedema Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Hereditary Angioedema Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Hereditary Angioedema Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hereditary Angioedema Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories